METHOD FOR MODULATING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) AGONIST INDUCED MUSCLE LOSS
METHOD FOR MODULATING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) AGONIST INDUCED MUSCLE LOSS
Provided herein is a method of ameliorating muscle loss in a subject induced from the treatment of the subject with a GLP-1 agonist with the administration to the subject of a therapeutically effective amount of a placenta derived biological material having a continuous lipid bilayer membrane